A new synuclein-transgenic mouse model for early Parkinson's reveals molecular features of preclinical disease
Diana M. Hendrickx, Pierre Garcia, Amer Ashrafi, Alessia Sciortino, Kristopher J. Schmit, Heike Kollmus, Nathalie Nicot, Tony Kaoma, Laurent Vallar, Manuel Buttini, Enrico Glaab
This study uses a synuclein-transgenic mouse model to identify molecular changes in early Parkinson's disease before neurodegeneration occurs.
Molecular Neurobiology · Sep 30, 2020Peer-reviewedNeuroscience